This is a preview of subscription content, log in via an institution to check access.
Notes
The study was partially funded by Bristol-Myers Squibb.
Reference
Younossi ZM, et al. Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the United States. Diabetes Care : 28 Oct 2019. Available from: URL: http://doi.org/10.2337/dc19-1113
Rights and permissions
About this article
Cite this article
Burden of non-alcoholic steatohepatitis substantial in T2DM. PharmacoEcon Outcomes News 841, 6 (2019). https://doi.org/10.1007/s40274-019-6358-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6358-8